Therapeutic Asset Ratings
234 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Trastuzumab Emtansine
estrogen-receptor positive breast cancer
Dana-Farber Cancer Institute
P2
CCC
(53)
Venetoclax
breast cancer
Dana-Farber Cancer Institute
P2
CCC
(53)
Zimberelimab
renal carcinoma
Dana-Farber Cancer Institute
P2
CCC
(53)
Blinatumomab
leukemia
Dana-Farber Cancer Institute
P2
CCC
(52)
Panobinostat
Breast Neoplasms
Dana-Farber Cancer Institute
P2
CCC
(52)
Zimberelimab
renal cell carcinoma
Dana-Farber Cancer Institute
P2
CCC
(52)
Casdatifan
kidney cancer
Dana-Farber Cancer Institute
P2
CCC
(51)
flt3 ligand
Melanoma
Dana-Farber Cancer Institute
P2
CCC
(51)
Sc-Peg
lymphoblastic lymphoma
Dana-Farber Cancer Institute
P2
CCC
(51)
VIPIVOTIDE TETRAXETAN
kidney cancer
Dana-Farber Cancer Institute
P2
CCC
(51)
Zimberelimab
kidney cancer
Dana-Farber Cancer Institute
P2
CCC
(51)
Metformin
ovarian cancer
Dana-Farber Cancer Institute
P2
CCC
(50)
pf-05212384
endometrial carcinoma
Dana-Farber Cancer Institute
P2
CCC
(49)
Atezolizumab
breast neoplasm
Dana-Farber Cancer Institute
P1/2
CCC
(49)
Copanlisib
relapsed/refractory diffuse large B-cell lymphoma
Dana-Farber Cancer Institute
P1/2
CCC
(49)
Belzutifan
cervical cancer
Dana-Farber Cancer Institute
P2
CCC
(48)
Belzutifan
endometrial carcinoma
Dana-Farber Cancer Institute
P2
CCC
(48)
Camibirstat
small cell lung carcinoma
Dana-Farber Cancer Institute
P2
CCC
(48)
Casdatifan
renal cell carcinoma
Dana-Farber Cancer Institute
P2
CCC
(48)
Dostarlimab
Her2-receptor negative breast cancer
Dana-Farber Cancer Institute
P2
CCC
(48)
ly3023414
endometrial carcinoma
Dana-Farber Cancer Institute
P2
CCC
(48)
Sc-Peg
acute lymphoblastic leukemia
Dana-Farber Cancer Institute
P2
CCC
(48)
VIPIVOTIDE TETRAXETAN
renal cell carcinoma
Dana-Farber Cancer Institute
P2
CCC
(48)
Aguix
pancreatic ductal adenocarcinoma
Dana-Farber Cancer Institute
P1/2
CCC
(48)
Tazemetostat
metastatic prostate carcinoma
Dana-Farber Cancer Institute
P1/2
CCC
(48)
Showing 101 to 125 of 234 assets
Previous
Page 5 of 10
Next